A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...

The innovative advance could shift treatment from response to prevention, and redefine how we think about this common maternal condition.

Click Therapeutics has collected a groundbreaking green light from the FDA for the agency’s first prescription digital ...

Would you try an electromagnetic headset that claims to ‘reset the vagus nerve’? Emilie Lavinia investigates the world of ...

The enforcement report was issued because the FDA placed this as a Class II recall, which the agency defines as “use of or ...

A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists-widely used in blockbuster ...

President Donald Trump s newly confirmed Food and Drug Administration Commissioner, Dr Marty Makary, emphasized that soul ...

The leading Postpartum Depression Companies such as GH Research, Reunion Neuroscience, Lipocine, Brii Biosciences Limited, ...

The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment ...

CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...